BioCorRx Begins Recruitment for Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder

ANAHEIM, CA, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the“Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that it...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials